McKesson Corporation (MCK) has risen sharply, recording gains of 11.01% in the past 4 weeks. However, the stock has corrected -0.29% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 3.99% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
McKesson Corporation (NYSE:MCK): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $196.78 and $195.82 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $196.96. The buying momentum continued till the end and the stock did not give up its gains. It closed at $196.57, notching a gain of 0.04% for the day. The total traded volume was 869,619 . The stock had closed at $196.50 on the previous day.
The stock has recorded a 20-day Moving Average of 3.35% and the 50-Day Moving Average is 6.66%. McKesson Corporation is up 10.45% in the last 3-month period. Year-to-Date the stock performance stands at 0%.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.